Tag: pfizer
-
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain’s National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following…
-
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain’s National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following…
-
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources
By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) – U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. A Pfizer exit from the consumer health business, which includes…
-
Mylan working to finalize EpiPen Medicaid settlement: CFO
Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss. The company had previously said it agreed to terms of a settlement set at…
-
ICU Medical to buy Pfizer’s infusion therapy business
(Reuters) – Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock, giving the drugmaker a stake of about…
-
ICU Medical to buy Pfizer’s infusion therapy business
(Reuters) – Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock, giving the drugmaker a stake of about…
-
Polish parliament rejects near-total abortion ban after protests
By Pawel Sobczak and Marcin Goettig WARSAW (Reuters) – Following protests by tens of thousands of women, Polish lawmakers on Thursday rejected plans for a near-total ban on abortion, in a hastily arranged vote that marks the first major domestic setback for the conservative government. The ruling Law and Justice party (PIS) unexpectedly withdrew its…
-
Palestinian president in hospital undergoing heart test: medical source
Palestinian President Mahmoud Abbas was taken to hospital in the occupied West Bank on Thursday and a medical source said the 81-year-old leader was undergoing a heart test. A statement carried by the official Palestinian news agency WAFA, and attributed to a presidential spokesman, said Abbas' “health condition is very normal”. Doctors planned to perform…
-
FDA panel recommends dropping serious warning on Pfizer’s Chantix
Pfizer's Chantix was approved about a decade ago, but thousands of reports of mental health problems in users led to the FDA imposing the “black box” warning – the most severe available – in 2009. On Wednesday, four of the 19 panelists voted to update the language in the box warning – of neuropsychiatric risks…